Connection
Maureen Leehey to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Maureen Leehey has written about Clinical Trials, Phase III as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.016 |
|
|
|
-
Lew MF, Pahwa R, Leehey M, Bertoni J, Kricorian G. Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease. Curr Med Res Opin. 2007 Apr; 23(4):741-50.
Score: 0.016